Document is current
Any future updates will be listed below
-
Authors
Moufarrej, Mira N. https://orcid.org/0000-0001-8953-4057
Vorperian, Sevahn K. https://orcid.org/0000-0003-0418-5260
Wong, Ronald J. https://orcid.org/0000-0003-1205-6936
Campos, Ana A.
Quaintance, Cecele C.
Sit, Rene V.
Tan, Michelle
Detweiler, Angela M.
Mekonen, Honey
Neff, Norma F. https://orcid.org/0000-0001-7141-5420
Baruch-Gravett, Courtney
Litch, James A. https://orcid.org/0000-0003-0570-0308
Druzin, Maurice L.
Winn, Virginia D. https://orcid.org/0000-0003-1136-2907
Shaw, Gary M.
Stevenson, David K.
Quake, Stephen R. https://orcid.org/0000-0002-1613-0809
- License Information
-
More Information
Article History
Received: 10 March 2021
Accepted: 6 January 2022
First Online: 9 February 2022
Competing interests
: M.N.M., S.K.V., G.M.S., D.K.S. and S.R.Q. are inventors on a patent application submitted by the Chan Zuckerberg Biohub and Stanford University that covers non-invasive early prediction of preeclampsia and monitoring maternal organ health over pregnancy (USPTO application number 63/159,400 filed on 10 March 2021 and 63/276,467 filed on 5 November 2021). S.R.Q. is a founder, consultant and shareholder of Mirvie. M.N.M. is also a shareholder of Mirvie.
